185 related articles for article (PubMed ID: 20627873)
1. Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect.
Huang L; Zhu C; Sun Y; Xie G; Mackenzie GG; Qiao G; Komninou D; Rigas B
Carcinogenesis; 2010 Nov; 31(11):1982-90. PubMed ID: 20627873
[TBL] [Abstract][Full Text] [Related]
2. Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice.
Mackenzie GG; Sun Y; Huang L; Xie G; Ouyang N; Gupta RC; Johnson F; Komninou D; Kopelovich L; Rigas B
Gastroenterology; 2010 Oct; 139(4):1320-32. PubMed ID: 20600034
[TBL] [Abstract][Full Text] [Related]
3. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
Mackenzie GG; Ouyang N; Xie G; Vrankova K; Huang L; Sun Y; Komninou D; Kopelovich L; Rigas B
Cancer Prev Res (Phila); 2011 Jul; 4(7):1052-60. PubMed ID: 21464038
[TBL] [Abstract][Full Text] [Related]
4. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
Whitt JD; Li N; Tinsley HN; Chen X; Zhang W; Li Y; Gary BD; Keeton AB; Xi Y; Abadi AH; Grizzle WE; Piazza GA
Cancer Prev Res (Phila); 2012 Jun; 5(6):822-33. PubMed ID: 22556201
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer.
Babbar N; Ignatenko NA; Casero RA; Gerner EW
J Biol Chem; 2003 Nov; 278(48):47762-75. PubMed ID: 14506281
[TBL] [Abstract][Full Text] [Related]
6. Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.
Zhao W; Mackenzie GG; Murray OT; Zhang Z; Rigas B
Carcinogenesis; 2009 Mar; 30(3):512-9. PubMed ID: 19136474
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
[TBL] [Abstract][Full Text] [Related]
8. Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition.
Tinsley HN; Gary BD; Thaiparambil J; Li N; Lu W; Li Y; Maxuitenko YY; Keeton AB; Piazza GA
Cancer Prev Res (Phila); 2010 Oct; 3(10):1303-13. PubMed ID: 20876730
[TBL] [Abstract][Full Text] [Related]
9. A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.
Piazza GA; Keeton AB; Tinsley HN; Gary BD; Whitt JD; Mathew B; Thaiparambil J; Coward L; Gorman G; Li Y; Sani B; Hobrath JV; Maxuitenko YY; Reynolds RC
Cancer Prev Res (Phila); 2009 Jun; 2(6):572-80. PubMed ID: 19470791
[TBL] [Abstract][Full Text] [Related]
10. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
Li X; Pathi SS; Safe S
BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
[TBL] [Abstract][Full Text] [Related]
11. Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells.
Qiao L; Shiff SJ; Rigas B
Int J Cancer; 1998 Mar; 76(1):99-104. PubMed ID: 9533768
[TBL] [Abstract][Full Text] [Related]
12. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
[TBL] [Abstract][Full Text] [Related]
13. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
[TBL] [Abstract][Full Text] [Related]
14. Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells.
Çoker A; Arısan ED; Palavan-Ünsal N
Mol Med Rep; 2012 Apr; 5(4):1037-42. PubMed ID: 22294330
[TBL] [Abstract][Full Text] [Related]
15. Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G.
Tinsley HN; Gary BD; Keeton AB; Zhang W; Abadi AH; Reynolds RC; Piazza GA
Mol Cancer Ther; 2009 Dec; 8(12):3331-40. PubMed ID: 19996273
[TBL] [Abstract][Full Text] [Related]
16. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.
Shiff SJ; Qiao L; Tsai LL; Rigas B
J Clin Invest; 1995 Jul; 96(1):491-503. PubMed ID: 7615821
[TBL] [Abstract][Full Text] [Related]
17. Sulindac activates NF-κB signaling in colon cancer cells.
Mladenova D; Pangon L; Currey N; Ng I; Musgrove EA; Grey ST; Kohonen-Corish MR
Cell Commun Signal; 2013 Oct; 11():73. PubMed ID: 24083678
[TBL] [Abstract][Full Text] [Related]
18. Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction.
Seo SK; Lee HC; Woo SH; Jin HO; Yoo DH; Lee SJ; An S; Choe TB; Park MJ; Hong SI; Park IC; Rhee CH
Apoptosis; 2007 Jan; 12(1):195-209. PubMed ID: 17136320
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR
Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
Gong EY; Shin YJ; Hwang IY; Kim JH; Kim SM; Moon JH; Shin JS; Lee DH; Hur DY; Jin DH; Hong SW; Lee WK; Lee WJ
Toxicol Lett; 2016 Sep; 258():126-133. PubMed ID: 27339904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
